CTRI/2019/02/017467Not yet recruiting未知
COMPARISON OF KETAMINE, LEVOBUPIVACAINE AND A COMBINATION OF BOTH AS PRE-INCISION SURGICAL SITE INFILTRATION FOR POSTOPERATIVE ANALGESIA AFTER ABDOMINAL HYSTERECTOMY
Vardhman Mahavir Medical College and Safdarjung Hospital0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients fulfilling the American society of Anaesthesiologists (ASA) physical status I or II criteria,age from 18years to 75years,Duration of surgery less than 2 hours
Exclusion Criteria
- •Patients with allergy to study drugs,cardiovascular disease (such as hypertension, tachycardia, arrhythmia, congestive heart failure, and coronary artery disease,Psychiatric disorder,Neurological disease, increased intracranial pressure, seizure disorder, glaucoma, hyperthyroidism
- •5.Liver or renal dysfunction.
Investigators
Similar Trials
Completed
Phase 2
comparing the effect ofKetamin; Bupivacain and Dexmedetomidine intraperitoneal in controlling the pain after operation in patients are candidates for abdominal hysterectomyIRCT20141209020258N130Arak University of Medical Sciences105
Not yet recruiting
Not Applicable
To know the effect of drug Nalbuphine and Ketamine in treating shivering in patients coming for below abdomen SurgeriesCTRI/2023/02/049546ESI medical college and hospital
Completed
Phase 3
Ropivacaine plus ketamine versus ropivacaine alone for Cesarean paiIRCT20221125056605N1Vice-Chancellery for Research Hormozgan University of Medical Sciences54
Not yet recruiting
Phase 4
observing the intravenous drugs ketamine, dexmeditomidine and combination of ketamine of dexmeditomidine in the mitigation of agitation following general anaesthesia in patients undergoing nasal surgeriesCTRI/2023/07/055886John Mammen
Recruiting
Phase 4
Comparison of two drugs, Lignocaine and Ketamine intravenous infusion in management of difficult cancer paiCTRI/2023/10/058966Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad